111 Operating Income Over Time
| YI Stock | USD 8.29 0.01 0.12% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out 111 Performance and 111 Correlation. Is there potential for Consumer Staples Distribution & Retail market expansion? Will 111 introduce new products? Factors like these will boost the valuation of 111. Anticipated expansion of 111 directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about 111 listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.84) | Revenue Per Share | Quarterly Revenue Growth (0.17) | Return On Assets | Return On Equity |
111 Inc's market price often diverges from its book value, the accounting figure shown on 111's balance sheet. Smart investors calculate 111's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since 111's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between 111's value and its price as these two are different measures arrived at by different means. Investors typically determine if 111 is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 111's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Income Analysis
Compare 111 Inc and related stocks such as Electrocore LLC, Rein Therapeutics, and Neuroone Medical Tec Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ECOR | (15 M) | (15 M) | (15 M) | (15 M) | (15 M) | (15 M) | (15 M) | (25.6 M) | (54.6 M) | (46.1 M) | (24.7 M) | (20 M) | (22.9 M) | (18.8 M) | (12.2 M) | (14 M) | (14.7 M) |
| RNTX | (20.5 K) | (20.5 K) | (20.5 K) | (20.5 K) | (20.5 K) | (20.5 K) | (20.5 K) | (20.5 K) | (20.5 K) | (20.5 K) | (20.5 K) | (26.6 K) | (27.6 K) | (16.3 K) | (65.1 M) | (58.6 M) | (55.7 M) |
| NMTC | (6 K) | (13.7 K) | (13.7 K) | (19.6 K) | (35.9 K) | (30.9 K) | (32.6 K) | (3.2 M) | (5.8 M) | (4.9 M) | (10.2 M) | (10 M) | (12 M) | (11.9 M) | (4.2 M) | (3.8 M) | (4 M) |
| DYAI | (190.8 K) | 1.6 M | 1.6 M | 556.5 K | (5.3 M) | (3.6 M) | (6 M) | (7.1 M) | (7.6 M) | (9.3 M) | (10 M) | (14.7 M) | (10.2 M) | (8.2 M) | (5.9 M) | (5.3 M) | (5.6 M) |
| RNXT | (3.9 M) | (3.9 M) | (3.9 M) | (3.9 M) | (3.9 M) | (3.9 M) | (3.9 M) | (3.9 M) | (3.9 M) | (3.9 M) | (3.2 M) | (5.7 M) | (9.9 M) | (11.4 M) | (11 M) | (9.9 M) | (10.4 M) |
| STRR | (12.9 M) | (3.5 M) | (5.1 M) | 171 K | 2.5 M | 2.8 M | 3.1 M | (6 M) | (4.5 M) | (1.9 M) | (7.2 M) | (11.6 M) | (3.1 M) | 1.4 M | (8.4 M) | (9.7 M) | (10.2 M) |
| ANVS | (354.9 K) | (1.8 M) | (1.8 M) | (682.4 K) | (682.4 K) | (682.4 K) | (682.4 K) | (682.4 K) | (713.9 K) | (1.6 M) | (6.6 M) | (14.5 M) | (25.5 M) | (45 M) | (26.7 M) | (24 M) | (22.8 M) |
| PYPD | (1.8 M) | (1.8 M) | (1.8 M) | (3.6 M) | (11.3 M) | (11.3 M) | (10.3 M) | (13.8 M) | (18.4 M) | (18.6 M) | (26.3 M) | (42.9 M) | (38.9 M) | (22.9 M) | (28 M) | (33 M) | (34.6 M) |
| CELU | (1.1 K) | (1.1 K) | (1.1 K) | (1.1 K) | (1.1 K) | (1.1 K) | (1.1 K) | (1.1 K) | (1.1 K) | (264.1 M) | (151.9 M) | (109.1 M) | (25.6 M) | (76.5 M) | (38.4 M) | (44.1 M) | (46.3 M) |
| ELUT | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (8.4 M) | (13.6 M) | (23 M) | (35.2 M) | (30.5 M) | (35.7 M) | (32.1 M) | (33.7 M) |
111 Inc and related stocks such as Electrocore LLC, Rein Therapeutics, and Neuroone Medical Tec Operating Income description
Operating Income is the amount of profit realized from 111 Inc operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of 111 Inc is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| 111 Inc | YI |
Specialization | Consumer Staples, Consumer Staples Distribution & Retail |
| Business Address | No295 ZuChongZhi Road, |
| Exchange | NASDAQ Exchange |
USD 8.29
Check out 111 Performance and 111 Correlation. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
111 technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.